SECTION 32
Section 32, the new venture fund launched by Bill Maris, was named in homage to Section 31, an intelligence agency from the Star Trek universe. Maris, the GV (Google Ventures) founder/former-CEO, has raised $150 million for the project that will focus on various investments. The fund will be run directly by Maris and primarily based out of San Diego.
SECTION 32
Industry:
Finance Financial Services Venture Capital
Founded:
2017-05-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Global Site Tag
Similar Organizations
ABRT
ABRT is a venture capital firm that invests primarily in software and internet companies.
Action Potential Venture Capital
Action Potential Venture Capital is a strategic venture capital fund that invests in bioelectronic medicine and technology companies.
MTech Capital
MTech Capital is a venture capital firm investing in InsurTech - technology companies operating in the insurance industry.
NTEC
NTEC is a Kuwait-based venture capital fund that invests in biotechnology, life sciences, IT, and energy companies.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-08 | Autobahn Therapeutics | Section 32 investment in Venture Round - Autobahn Therapeutics | 32.7 M USD |
| 2022-08-24 | Spectral | Section 32 investment in Venture Round - Spectral | 23 M USD |
| 2022-08-23 | Inworld AI | Section 32 investment in Series A - Inworld AI | 50 M USD |
| 2022-07-20 | BigHat Biosciences | Section 32 investment in Series B - BigHat Biosciences | 75 M USD |
| 2022-07-15 | Phaidra | Section 32 investment in Series A - Phaidra | 25 M USD |
| 2022-07-13 | Swadesh | Section 32 investment in Pre Seed Round - Swadesh | 2.25 M USD |
| 2022-06-13 | Manifold Bio | Section 32 investment in Series A - Manifold Bio | 40 M USD |
| 2022-05-17 | Character Biosciences | Section 32 investment in Series A - Character Biosciences | 18 M USD |
| 2022-05-12 | Legacy | Section 32 investment in Series B - Legacy | 25 M USD |
| 2022-05-10 | MOMA Therapeutics | Section 32 investment in Series B - MOMA Therapeutics | 150 M USD |